“Favorable Safety Profile of Tirbanibulin Ointment 1% for Actinic Keratosis: Pooled Results from Two Phase III Studies”, J of Skin, vol. 4, no. 6, p. s120, Oct. 2020, doi: 10.25251/skin.4.supp.120.